Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 240,161 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 18.75 | Mínimo Máximo |
|||||
| Minimo del Dia | 17.84 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| LENZ Therapeutics Inc | LENZ | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.26 | -1.42% | 18.06 | 16:30:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 18.38 | 17.84 | 18.75 | 18.06 | 18.32 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 3,645 | 240,161 | US$ 18.17 | US$ 4,362,984 | - | 14.42 - 24.59 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 15:00:06 | 1 | US$ 18.00 | USD |
Información Financiera LENZ Therapeutics Inc LENZ
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 459.88M | 25.53M | - | 0 | -124.65M | -4.88 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre LENZ Therapeutics Inc LENZ
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 10/6/2024 | 07:00 | GlobeNewswire Inc. | LENZ Therapeutics to Host Key Opinion Leader Event on June.. |
| 30/5/2024 | 07:00 | GlobeNewswire Inc. | LENZ Therapeutics to Present at the Jefferies Global.. |
| 21/5/2024 | 07:31 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 09/5/2024 | 15:18 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 08/5/2024 | 16:11 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 08/5/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 08/5/2024 | 15:01 | GlobeNewswire Inc. | LENZ Therapeutics Reports First Quarter 2024 Financial.. |
| 01/5/2024 | 15:01 | GlobeNewswire Inc. | LENZ Therapeutics to Report First Quarter Financial Results.. |
| 03/4/2024 | 06:00 | Business Wire | LENZ Therapeutics Announces Positive Topline Data from Phase.. |
| 02/4/2024 | 15:01 | Business Wire | LENZ Therapeutics to Host Investor Call to Discuss Topline.. |
Histórico de Datos LENZ
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.64 | 19.48 | 17.64 | 18.48 | 173,063 | 0.42 | 2.38% |
| 1 Month | 18.29 | 19.98 | 14.42 | 16.66 | 179,742 | -0.23 | -1.26% |
| 3 Months | 21.15 | 24.59 | 14.42 | 17.16 | 157,524 | -3.09 | -14.61% |
| 6 Months | 15.98 | 24.59 | 14.42 | 17.30 | 158,436 | 2.08 | 13.02% |
| 1 Year | 15.98 | 24.59 | 14.42 | 17.30 | 158,436 | 2.08 | 13.02% |
| 3 Years | 15.98 | 24.59 | 14.42 | 17.30 | 158,436 | 2.08 | 13.02% |
| 5 Years | 15.98 | 24.59 | 14.42 | 17.30 | 158,436 | 2.08 | 13.02% |
